Interpace Biosciences Inc ROCE
What is the ROCE of Interpace Biosciences Inc?
The ROCE of Interpace Biosciences Inc is -30.89%
What is the definition of ROCE?
Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used.
= EBIT / (assets - current liabilities)
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with roce similar to Interpace Biosciences Inc
- OBITX has ROCE of -30.96%
- Vistagen Therapeutics has ROCE of -30.93%
- TOMI Environmental Solutions has ROCE of -30.93%
- Medicenna Therapeutics has ROCE of -30.92%
- InfraStrata Plc has ROCE of -30.92%
- Antibe Therapeutics has ROCE of -30.90%
- Interpace Biosciences Inc has ROCE of -30.89%
- Provexis plc has ROCE of -30.88%
- KRM22 Plc has ROCE of -30.87%
- Treasure ASA has ROCE of -30.86%
- Germinate Capital has ROCE of -30.81%
- Boxlight has ROCE of -30.77%
- Duke Offshore has ROCE of -30.75%